IHH Healthcare Berhad: Director Share Disposal – Investor Update
IHH Healthcare Berhad: Significant Share Disposal by Non-Executive Director
Key Points
- Director Involved: Mr. Mehmet Ali Aydinlar, Non-Executive Director of IHH Healthcare Berhad.
- Transaction Dates: 24 December 2025 and 26 December 2025.
- Nature of Transactions: Disposal of ordinary shares, conducted outside the closed period.
- Total Shares Disposed: 1,404,600 ordinary shares.
- Consideration Received: MYR 8.610 per share (24 Dec 2025), MYR 8.581 per share (26 Dec 2025).
- Percentage of Shares Disposed: 0.008% (24 Dec), 0.007% (26 Dec) of IHH’s issued ordinary shares.
Detailed Breakdown
| Date |
Shares Disposed |
Consideration (MYR per share) |
Total Value (MYR) |
% of Company’s Shares |
| 24 Dec 2025 |
750,000 |
8.610 |
6,457,500 |
0.008% |
| 26 Dec 2025 |
654,600 |
8.581 |
5,617,212.60 |
0.007% |
Post-Transaction Shareholding
Following these disposals, Mr. Mehmet Ali Aydinlar’s holdings are as follows:
Direct Interest
- Citigroup Nominees (Asing) Sdn Bhd, nominee of UBS Switzerland AG: 7,000,000 ordinary shares
- Citigroup Nominees (Asing) Sdn Bhd, UBS Switzerland AG for Mehmet Ali Aydinlar: 948,000 ordinary shares
Indirect Interest
- Citigroup Nominees (Asing) Sdn Bhd, nominee of UBS Switzerland AG: 7,000,000 ordinary shares
- Raffles Nominees (Pte) Limited: 207,620,000 ordinary shares
- Citigroup Nominees (Asing) Sdn Bhd, UBS Switzerland AG for SZA Gayrimenkul Yatirim Insaat ve Ticaret Anonim Sirketi: 300,248,873 ordinary shares
Potential Impact on Shareholders
The disposal of shares by a Non-Executive Director is generally considered a material event, especially for institutional and retail investors tracking insider activity. While the percentage of shares sold is relatively small (0.015% combined), the timing and nature of the sales—conducted outside the closed period—may prompt speculation about the director’s outlook or personal financial considerations.
Investors often interpret director share disposals as potential signals, though the sale volume here is not significant enough to suggest a major change in confidence. However, the transaction prices provide a recent valuation benchmark for the shares, which could influence market sentiment and trading activity.
Shareholders should monitor future filings for additional insider transactions, which could cumulatively impact confidence and potentially the share price if larger disposals occur or if other insiders follow suit.
Conclusion
While the share disposals by Mr. Mehmet Ali Aydinlar are not large in proportion to the total shares, they are noteworthy for those tracking insider activity at IHH Healthcare Berhad. The transactions may have minor short-term effects on market sentiment, but do not represent a major shift in ownership or control.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult financial professionals before making investment decisions. The information provided is based on publicly available company filings as of the date of announcement.
View IHH Historical chart here
